Search research articles
Contact Us
Filters
Showing results (11-20 of 225) with videos related to
Page
of 23
Sort By:
Molecular Cancer
|
March 31, 2019
Extracellular vesicles in the tumor microenvironment: old stories, but new tales
Liu Han, Eric W-F Lam, Yu Sun
Aging Cell
|
November 20, 2018
Senescent cells: A new Achilles' heel to exploit for cancer medicine?
Boyi Zhang, Eric W-F Lam, Yu Sun
Plos One
|
October 8, 2010
Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1
Ana Lúcia Mena, Eric W-F Lam, Sukalyan Chatterjee
Chinese Journal of Cancer
|
May 28, 2013
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
Ana R Gomes, Fung Zhao, Eric W F Lam
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 4, 2011
Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer
Yolanda Olmos, Jan J Brosens, Eric W-F Lam
The Journal of Endocrinology
|
March 9, 2011
The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer
Eric W-F Lam, Kunal Shah, Jan J Brosens
Trends in Molecular Medicine
|
August 30, 2018
Cellular Senescence: The Sought or the Unwanted?
Yu Sun, Jean-Philippe Coppé, Eric W-F Lam
Cell Cycle (Georgetown, Tex.)
|
October 18, 2008
Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
Ana R Gomes, Jan J Brosens, Eric W-F Lam
The Biochemical Journal
|
July 26, 2002
An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase
Silvia Fernández de Mattos, Eric W-F Lam, Albert Tauler
Biochimica Et Biophysica Acta
|
October 8, 2011
FOXM1: From cancer initiation to progression and treatment
Chuay-Yeng Koo, Kyle W Muir, Eric W-F Lam
Page
of 23
Search research articles
Search
Showing results (11-20 of 225) with videos related to
Sort By:
Page
of 23
Molecular Cancer
|
March 31, 2019
Extracellular vesicles in the tumor microenvironment: old stories, but new tales
Liu Han, Eric W-F Lam, Yu Sun
Aging Cell
|
November 20, 2018
Senescent cells: A new Achilles' heel to exploit for cancer medicine?
Boyi Zhang, Eric W-F Lam, Yu Sun
Plos One
|
October 8, 2010
Sustained spindle-assembly checkpoint response requires de novo transcription and translation of cyclin B1
Ana Lúcia Mena, Eric W-F Lam, Sukalyan Chatterjee
Chinese Journal of Cancer
|
May 28, 2013
Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
Ana R Gomes, Fung Zhao, Eric W F Lam
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 4, 2011
Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer
Yolanda Olmos, Jan J Brosens, Eric W-F Lam
The Journal of Endocrinology
|
March 9, 2011
The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer
Eric W-F Lam, Kunal Shah, Jan J Brosens
Trends in Molecular Medicine
|
August 30, 2018
Cellular Senescence: The Sought or the Unwanted?
Yu Sun, Jean-Philippe Coppé, Eric W-F Lam
Cell Cycle (Georgetown, Tex.)
|
October 18, 2008
Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
Ana R Gomes, Jan J Brosens, Eric W-F Lam
The Biochemical Journal
|
July 26, 2002
An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase
Silvia Fernández de Mattos, Eric W-F Lam, Albert Tauler
Biochimica Et Biophysica Acta
|
October 8, 2011
FOXM1: From cancer initiation to progression and treatment
Chuay-Yeng Koo, Kyle W Muir, Eric W-F Lam
Page
of 23